NCT03485417View on ClinicalTrials.gov

Substance Misuse To Psychosis for Stimulants

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

165

Participants

Timeline

Start Date

June 1, 2019

Primary Completion Date

May 31, 2024

Study Completion Date

May 31, 2025

Conditions

Stimulant Use With Stimulant-Induced Psychotic Disorder (Diagnosis)Schizophrenia and Related DisordersStimulant DependenceStimulant AbusePharmacotherapy

Interventions

DRUG

Aripiprazole

for oral or depot preparation

DRUG

Paliperidone

for oral or depot

OTHER

Treatment as Usual

to be decided by treating psychiatrist with Rx other than aripiprazole or paliperidone

Trial Locations (1)

000000

Queen Mary Hospital, Hong Kong

All Listed Sponsors

collaborator

Queen Mary Hospital, Hong Kong

OTHER

collaborator

North District Hospital

OTHER

lead

The University of Hong Kong

OTHER

NCT03485417 - Substance Misuse To Psychosis for Stimulants | Biotech Hunter | Biotech Hunter